Clinical trial
PEERLESS II: RCT of FlowTriever vs. Anticoagulation Alone in Pulmonary Embolism
NCT06055920 is registered in ClinicalTrials.gov with Inari Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PEERLESS II: RCT of FlowTriever vs. Anticoagulation Alone in Pulmonary Embolism
- Lead sponsor
- Inari Medical
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 17, 2023
- Completion date
- October 31, 2026
- Enrollment
- 1,200 (estimated)
- Sites
- 72
Conditions
As the registry lists them; a condition with its own page is linked.